Report Type
Single Stock Research Reports
Recent single stock reports highlight a recurring theme of solid top-line performance paired with aggressive strategic reinvestment, though varied operational headwinds are impacting near-term profitability across sectors. Veralto and Fluence Energy reported revenue largely in line with expectations, yet experienced contrasting margin outcomes; Veralto achieved a 24.6% operating margin beat, while Fluence's gross margins were compressed to 5.6% due to project-specific cost overruns. In the technology space, Alphabet’s massive AI build-out is reflected in 2026 Capex guidance of $175-185 billion, a shift that is forcing analysts to abandon free cash flow yield in favor of P/E and EBITDA valuation frameworks. Growth outlooks remain cautious, with Match Group signaling softer 2026 revenue due to regulatory costs and Veralto projecting moderate sales growth between LSD+ and MSD+. Macroeconomic risks are also tempering sentiment, as evidenced by downgrades for Harbour Energy driven by anticipated 2026 LNG oversupply and high leverage. Collectively, these reports underscore a market environment where robust demand and backlogs, such as Fluence’s $5.5 billion, must be weighed against rising capital intensity and shifting valuation metrics.
578 reports available
All reports
Page 20 of 24
Ramaco Resources Inc. Coal Business to Improve
Goldman Sachs · May 13, 2026
Guidance Raise Clears a High Bar
Goldman Sachs · May 13, 2026
Nemluvio Navigator Strong Prescription Trends Support Blockbuster Run Rate Guide
Goldman Sachs · May 13, 2026
AuM First Take: Solid Fundraising Momentum
Goldman Sachs · May 13, 2026
Alstom FY25/26 Release and Outlook
Goldman Sachs · May 13, 2026
ABN Amro Bank Q1 2026 First Look
Goldman Sachs · May 13, 2026
Allianz Results First Take
Goldman Sachs · May 13, 2026
Aristocrat Leisure 1H26 First Take
Goldman Sachs · May 13, 2026
ASML Holding Catalyst Rich 2026 Bodes Well for Path to €1600 Per Share
Goldman Sachs · May 13, 2026
Simon Property Group 1Q26 First Look
Barclays · May 12, 2026
Hannover Re Data Update Following 1Q26 Results
Goldman Sachs · May 11, 2026
Philip Morris International: ZYN Ultra Rollout Following FDA Guidance
Goldman Sachs · May 11, 2026
National Bank of Greece Updating Estimates Post Q1
Goldman Sachs · May 11, 2026
Apogee Therapeutics Analysis: Zumilokibart in Atopic Dermatitis
Goldman Sachs · May 11, 2026
ITT Inc. FY26 Guide Conservative
Goldman Sachs · May 11, 2026
Bank of China 1Q26 Post Result NDR Takeaways
Goldman Sachs · May 11, 2026
Madison Air Solutions Specialty HVAC Business Analysis
Goldman Sachs · May 11, 2026
Updating Estimates Post 1Q26 Amadeus IT Group
Goldman Sachs · May 11, 2026
Shift Up Corp 1Q26 Review
Goldman Sachs · May 11, 2026
Softbank Corp Upside Potential and New Medium Term Plan
Goldman Sachs · May 11, 2026
Updating Estimates Post Q1 2026
Goldman Sachs · May 11, 2026
Firefly Aerospace Launch Progress
Goldman Sachs · May 11, 2026
Konami Group 4Q Earnings Review
Goldman Sachs · May 11, 2026
Nippon Yusen Earnings Review
Goldman Sachs · May 11, 2026